Chronic treatment with tetrahydrobiopterin reverses endothelial dysfunction and oxidative stress in hypercholesterolaemia.
about
Human endothelial dihydrofolate reductase low activity limits vascular tetrahydrobiopterin recyclingRole for Tetrahydrobiopterin in the Fetoplacental Endothelial Dysfunction in Maternal Supraphysiological HypercholesterolemiaRecoupling the cardiac nitric oxide synthases: tetrahydrobiopterin synthesis and recyclingYou're only as old as your arteries: translational strategies for preserving vascular endothelial function with agingLocal tetrahydrobiopterin administration augments cutaneous vasoconstriction in aged humans.Tetrahydrobiopterin in cardiovascular health and disease.Tetrahydrobiopterin does not affect end-organ responsiveness to norepinephrine-mediated vasoconstriction in aged skin.Tetrahydrobiopterin, superoxide, and vascular dysfunction.Local tetrahydrobiopterin administration augments reflex cutaneous vasodilation through nitric oxide-dependent mechanisms in aged human skin.Reduced LDL-cholesterol levels in patients with coronary artery disease are paralleled by improved endothelial function: An observational study in patients from 2003 and 2007Hypercholesterolemia-induced erectile dysfunction: endothelial nitric oxide synthase (eNOS) uncoupling in the mouse penis by NAD(P)H oxidase.Systemic and vascular oxidation limits the efficacy of oral tetrahydrobiopterin treatment in patients with coronary artery disease.Tetrahydrobiopterin increases NO-dependent vasodilation in hypercholesterolemic human skin through eNOS-coupling mechanismsReduction of radiation-induced vascular nitrosative stress by the vitamin E analog γ-tocotrienol: evidence of a role for tetrahydrobiopterin.Erythropoietin prevents endothelial dysfunction in GTP-cyclohydrolase I-deficient hph1 miceTetrahydrobiopterin improves endothelial function in cardiovascular disease: a systematic reviewOral sapropterin acutely augments reflex vasodilation in aged human skin through nitric oxide-dependent mechanisms.Tetrahydrobiopterin restores diastolic function and attenuates superoxide production in ovariectomized mRen2.Lewis ratsTetrahydrobiopterin lowers muscle sympathetic nerve activity and improves augmentation index in patients with chronic kidney disease.Overexpression of GTP cyclohydrolase 1 feedback regulatory protein is protective in a murine model of septic shock.Suppression of eNOS-derived superoxide by caveolin-1: a biopterin-dependent mechanismPPAR-α Agonist Fenofibrate Upregulates Tetrahydrobiopterin Level through Increasing the Expression of Guanosine 5'-Triphosphate Cyclohydrolase-I in Human Umbilical Vein Endothelial Cells.Novel strategies to ameliorate radiation injury: a possible role for tetrahydrobiopterinTetrahydrobiopterin improves endothelial function and decreases arterial stiffness in estrogen-deficient postmenopausal women.Endothelial dysfunction and diabetes: effects on angiogenesis, vascular remodeling, and wound healing.The influence of sulforaphane on vascular health and its relevance to nutritional approaches to prevent cardiovascular disease.Tetrahydrobiopterin Supplementation Improves Endothelial Function But Does Not Alter Aortic Stiffness in Patients With Rheumatoid Arthritis.Vascular protection by tetrahydrobiopterin: progress and therapeutic prospectsTetrahydrobiopterin ameliorates the exaggerated exercise pressor response in patients with chronic kidney disease: a randomized controlled trialObstructive sleep apnea: the new cardiovascular disease. Part I: Obstructive sleep apnea and the pathogenesis of vascular disease.Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics.Nitric oxide synthase gene therapy: progress and prospects.Induction of vascular GTP-cyclohydrolase I and endogenous tetrahydrobiopterin synthesis protect against inflammation-induced endothelial dysfunction in human atherosclerosis.Rapid, direct effects of statin treatment on arterial redox state and nitric oxide bioavailability in human atherosclerosis via tetrahydrobiopterin-mediated endothelial nitric oxide synthase coupling.Synthesis and recycling of tetrahydrobiopterin in endothelial function and vascular disease.Role of oxidative stress in the pathogenesis of sickle cell disease.Tackling endothelial dysfunction by modulating NOS uncoupling: new insights into its pathogenesis and therapeutic possibilities.Oxidative stress and early atherosclerosis: novel antioxidant treatment.Role of Exercise-Induced Oxidative Stress in Sickle Cell Trait and Disease.Small molecules as therapeutic agents for inborn errors of metabolism.
P2860
Q24293579-E3138A4C-EAF4-485A-964E-A3A718DA00B1Q26772291-FBD56FE3-428B-400F-86DC-50BE3F018D3CQ26822833-BD16B072-936D-49AC-B2CC-78F92CF62566Q26824357-D264F996-9510-4225-8577-8E48A6A40E5DQ33459010-4F07EA3C-5740-4A20-8ABF-2EC7D7B92215Q33687812-6569E007-9B92-4751-ADF1-3A427B65EC38Q33711785-3435E31D-3FC8-4F4E-8C18-ED9A6AD2639DQ33779913-E368E28C-0FD1-4EAB-BD74-DA432896962FQ34097506-DD2F47A8-135E-4F31-B5A8-51D867903507Q34159297-30E624A0-71FE-4743-966F-C167F12BDBCFQ34217495-0AE31A62-228D-407C-BD90-57D63B75EC0CQ34252918-40A8559C-4EEF-4A6C-838F-076A5076F3F4Q34495148-EF9FD46B-2492-439F-A9B6-17806C6CBCC9Q34504618-5D078638-65B1-4C68-91A1-ECC676DAECCEQ34668310-972CF910-07CB-44E6-8517-77506769D88AQ34753845-EA22B00D-486A-4227-8A7A-6C9A62A466EEQ34762233-1FEEBACC-F5CF-4525-B5F7-DC3F05F1FD16Q35001320-F1649BBF-A128-422A-8852-EC628DEF28A6Q35035498-352B25FF-05EC-400F-B1D6-0374EEAC95F1Q35210026-4CA6CD8C-261D-4B96-A478-8A15C1A99724Q35315250-C8450694-432E-476D-97DA-B291B7799963Q35608768-B97602AB-C252-4FCC-9215-FA77535B69BEQ35848552-FD71F793-255A-43A1-AB4B-C2F711660E98Q35850060-2934875D-6004-4FBB-BBAE-C72DA6D0C273Q35947546-AF93D060-0D82-4AD0-AC5A-A0EE51FB8C99Q36117830-2353600E-2D61-4DBE-885F-FE1B2F0495F7Q36714071-3A8712AD-7FBF-4787-BA09-E25A9F8AF6DFQ37087728-8FBD0D4F-9E73-45AD-88BB-A5E8659AA416Q37211804-EA77B09E-5DC3-44E8-B735-29ADDB524961Q37275639-769BB8C8-7607-448C-9EE6-AB437A614D79Q37420916-D6392039-246E-4589-8A18-706E99173602Q37492606-3C9C9BF3-0416-4CEE-81BE-5AE5516B2E37Q37588140-9A9A35B3-948B-480C-9546-A5A8122F63CCQ37709733-595FB06E-6467-4890-BCF8-FFCA28CC0876Q37873087-BC779C4F-60F4-4AF9-9007-20350C754DB0Q37963311-8A21EFA8-4434-4FFC-9B5C-2E22062D0A60Q37968218-C4A40751-8D27-4812-ABA5-C3593B74E7C6Q38269619-7E5E7D92-C9A8-4CDF-ABBD-AA7F89333868Q38669072-EEAFA9FB-3009-4F6E-A8BE-F096795D2024Q39038060-B608F4AB-9632-44FF-858F-53E556CBA4C5
P2860
Chronic treatment with tetrahydrobiopterin reverses endothelial dysfunction and oxidative stress in hypercholesterolaemia.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Chronic treatment with tetrahy ...... ress in hypercholesterolaemia.
@en
Chronic treatment with tetrahy ...... ress in hypercholesterolaemia.
@nl
type
label
Chronic treatment with tetrahy ...... ress in hypercholesterolaemia.
@en
Chronic treatment with tetrahy ...... ress in hypercholesterolaemia.
@nl
prefLabel
Chronic treatment with tetrahy ...... ress in hypercholesterolaemia.
@en
Chronic treatment with tetrahy ...... ress in hypercholesterolaemia.
@nl
P2093
P50
P356
P1433
P1476
Chronic treatment with tetrahy ...... ress in hypercholesterolaemia.
@en
P2093
C Delli Gatti
D Hürlimann
F Enseleit
F Ruschitzka
K M Channon
R Chenevard
P304
P356
10.1136/HRT.2007.122184
P407
P577
2007-10-04T00:00:00Z